R R Reinhardt, … , V C Manganiello, C A Bondy J Clin Invest. 1995;95(4):1528-1538. https://doi.org/10.1172/JCI117825. Type III cGMP-inhibited phosphodiesterases (PDE3s) play important roles in hormonal regulation of lipolysis, platelet aggregation, myocardial contractility, and smooth muscle relaxation. We have recently characterized two PDE3 subtypes (PDE3A and PDE3B) as products of distinct but related genes. To elucidate their biological roles, in this study we compare cellular patterns of gene expression for these two enzymes during rat embryonic and postnatal development using in situ hybridization. PDE3B [corrected] mRNA is abundant in adipose tissue and is also expressed in hepatocytes throughout development. This mRNA is also highly abundant in embryonic neuroepithelium including the neural retina, but expression is greatly reduced in the mature nervous system. Finally, PDE3B
Introduction
Cyclic nucleotide phosphodiesterases (PDEs)1 are critical determinants of intracellular cyclic nucleotide concentrations and, consequently, of biological processes mediated by these important second messengers ( 1, 2) . There are at least seven distinct main-malian PDE gene families which differ in biochemical and physical properties, responses to specific effectors, inhibitors and therapeutic agents, and regulatory control mechanisms (1) (2) (3) . PDEs share a common domain organization pattern, all containing conserved catalytic domains of -270 amino acids (usually in the COOH-terminal regions) with divergent NH2-terminal domains (1) (2) (3) (4) . Most of the PDE gene families contain at least two subfamilies which are products of distinct but related genes or which arise by alternative splicing or differentially regulated transcription initiation mechanisms. For example, five different type I calmodulin-sensitive (5) (6) (7) and four type IV cAMP-specific (8, 9) PDE subfamilies have been identified. Although in some instances specific PDEs are relatively highly concentrated in individual cells, such as a type H cGMP-stimulated PDE in bovine adrenal glomerulosa cells (10) , multiple PDE types are usually present in most cells, in different amounts, proportions, and subcellular locations (1, 2) . Thus, intracellular cyclic nucleotide hydrolysis is a regulated process dependent on the coordinated and integrated activities of several structurally related but differentially expressed and regulated PDE isoenzymes.
Type III PDEs (PDE3s), commonly referred to as cGMPinhibited cyclic nucleotide phosphodiesterases ( 11), have been isolated from a number of tissues, including adipose tissue ( 12), platelets (13) , myocardium (14) , vascular (15, 16) and tracheo-bronchial (17, 18) smooth muscle preparations, liver (19, 20) , placenta (21) , and lymphocytes (22) . PDE3s are characterized by a high affinity for cAMP and cGMP, with the V,,.
higher for cAMP. Hydrolysis of cAMP by PDE3s is potently inhibited by cGMP, cilostamide, and a number of compounds, such as milrinone and enoximone, with inotropic/vasodilatory/ antiplatelet aggregatory properties ( 11, (23) (24) (25) (26) (27) . The subcellular distribution of PDE3s varies, with the enzyme predominantly microsomal in adipocytes (11, 12, 28, 29) and liver (19, 20) , cytosolic in platelets (13, 30) , and both cytosolic and membrane-associated in myocardium (31) (32) (33) . In rat adipocytes, activation of a particulate PDE3 is an important component in the antilipolytic action of insulin (11, 12, 28, 29, 34, 35) . Results from various studies using specific PDE3 inhibitors and cAMP analogues suggest that PDE3s regulate cAMP pools involved in the hormonal control of lipolysis, glycogenolysis, myocardial contractility, smooth muscle relaxation, and platelet aggregation (11, 14, 16-18, 23-27, 30, 31, 34-37) . It has also been suggested that in certain cells, e.g., platelets and lymphocytes, some effects of nitric oxide, which activates guanyl cyclase to increase cGMP, are mediated via increases in cAMP brought about by cGMP-inhibition of PDE3s (38, 39) .
We have cloned cDNAs for two cGMP-inhibited cyclic nucleotide phosphodiesterases (40, 41) , which in accord with the desire to develop a common nomenclature in this field, we will refer to as PDE3A and PDE3B. These enzymes are products of distinct but related genes; PDE3A mRNA is highly expressed in rat adipocytes, whereas PDE3B mRNA is highly expressed
PDE3A and PDE3B demonstrate distinctive patterns of gene expression in the rat fetus. A sagittal section through an embryonic day 20 (E20) fetus stained with hematoxylin and eosin (HE) is shown in A. That section and adjacent serial sections were hybridized to PDE3A antisense (B) or sense (D) and PDE3B antisense (C) or sense (E) probes, and the resulting hybridization patterns are shown in film autoradiographs. PDE3A mRNA is most abundant in adipose tissue, including the brown fat (bf ) of the dorsal fat pad and also in collections of white fat (arrowheads). PDE3B mRNA is most abundant in the gastrointestinal (gi) and cardiovascular systems. The heart is not included in these sections, but the PDE3B hybrids in the vasculature appear as pockmarks throughout embryonic tissues. Both transcripts are relatively plentiful in the dorsal root ganglia (drg), bladder (b), liver (i), lung (lu), spinal cord (sc), submandibular gland (sg), and stomach (st). in rat cardiac tissue (41) . To better understand biological roles of the two PDE3 subtypes, we have used in situ hybridization to investigate cellular patterns of PDE3A and PDE3B gene expression during embryonic and postnatal development in the rat. Our results show that PDE3A and PDE3B mRNAs exhibit unique and distinctive spatiotemporal patterns of expression, supporting the view that each of these two enzymes serves a cell-and developmental stage-specific biological role. 
Methods
of Child Health and Human Development Animal Use Committee. Rats were decapitated after carbon dioxide anesthesia and tissues were re-Tissue. Sprague-Dawley rats were obtained from Taconic Farms (Ger-moved and immediately frozen over dry ice before sectioning on a mantown, NY) and used in a protocol approved by the National Institute cryostat at a thickness of 10 Am. Timed pregnant dams were obtained bovine alkaline phosphatase, and transformed into Escherichia coli DH5a. Plasmids were extracted by the alkaline lysis method and digested with BamHI (PDE3A) or EcoRI (PDE3B) to verify the length of inserts and with XhoI (PDE3A) or with SacII and NdeI (PDE3B) for determination of orientation of inserts. For linearization of the plasmids, each clone was digested with Sall for sense or Spel for antisense and were used for in situ hybridization. These two antisense probes identified distinct bands when used in Northern hybridization (data not shown).
In situ hybridization. The synthesis of 35S-labeled cRNA probes and in situ hybridization protocol has been previously described (42) . In brief, high specific activity, double-labeled cRNA probes were synthe- PDE3B mRNA is highly abundant in smooth muscle and endothelium of the aorta (Ao) and is also highly expressed in the autonomic ganglion (g) embedded in connective tissue next to the aorta. PDE3A mRNA is selectively localized in the periaortic fat, where the hybridization is so strong that the fat cells look black with exposed silver grains. Bar = 100 ym. the DNA template was removed by digestion with DNase I at 370C for 10 min. Radiolabeled cRNA was separated from unincorporated nucleotides with sterile gel chromatography spin columns (Bio Spin 6;
Bio-Rad Laboratories, Richmond, CA), precipitated with 5 jil tRNA (10 ig/ml), 10 /id NaCl (5 M), 10 til DPEC-H20, and 300 ji cold ethanol, frozen on dry ice for 30 min, and centrifuged (10,000 g, 30 min at 40C). The purified probes were shortened to an average length of -150 bases by controlled alkaline hydrolysis. Average specific activity of probes generated by this protocol was 2-3 x 0l dpm/[g. Before hybridization, sections were warmed to 250C, fixed in 4% formaldehyde, and soaked for 10 min in 0.25% acetic anhydride/0.1 M triethanolamine hydrochloride/0.9% NaCl. Tissue was dehydrated through an ethanol series, dilipidated in chloroform, rehydrated, and air-dried. 35S-labeled probes were added to hybridization buffer (107 cpm/ml) composed of 50% formamide, 0.3 M NaCl, 20 mM Tris-HCl, pH 8, 5 mM EDTA, 500 jtg tRNA/ml, 10% dextran sulfate, 10 mM dithiothreitol, and 0.2% each of BSA, Ficoll, and polyvinylpyrollidone. Hybridization buffer was added to slides which were coverslipped and placed in humidified chambers overnight (14 h ) at 550C. Slides were washed several times in 4 x SSC to remove cover slips and hybridization buffer, dehydrated and immersed in 0.3 M NaCl, 50% formamide, 20 mM Tris-HCl, 1 mM EDTA at 60'C for 15 min. Sections were then treated with RNase A (20 jig/ml) for 30 min at 370C, passed through graded salt solutions (2x, lx, and 0.5 x SSC), followed by a 15-min wash in 0.1 x SSC at 50°C. Slides were air dried and apposed to Hyperfilm-beta Max (Amersham Corp., Arlington Heights, IL) for 3-6 d and then dipped in Kodak NTB2 nuclear emulsion, stored with desiccant at 4°C for 5-20 d, developed, and stained with hematoxylin and eosin for microscopic evaluation.
Control sense probes for PDE3A and PDE3B were used on parallel sections from embryos and most of the adult tissues (heart, kidney, liver, fat, and blood vessels) examined in this study and showed that background or nonspecific signal was extremely low (Figs. 1 and 2 ).
Tissues from a minimum of two animals were evaluated at each time point studied and two to six anatomically matched sections from each sample were hybridized to each probe; the data which are reported are based on consistent observations in multiple tissue sections. In the developmental aspect of the study, embryo, postnatal, and adult tissues were prepared identically, hybridized with the same batch of labeled probe, washed, exposed, and developed together to facilitate comparison of signal level at the different stages.
Results
Anatomical patterns of PDE3A and PDE3B gene expression were evaluated in sagittal sections through entire E15 and E20 rat embryos. The basic patterns established at El5 are conserved at E20 and are shown in Fig. 1 . PDE3A mRNA is most abundant in adipose tissue, including both brown and white fat (Figs. 1 and 2). It is expressed at lower levels in a diffuse pattern in lung and liver parenchyma and throughout the nervous system ( Fig. 1 B) . PDE3B mRNA's distribution is clearly distinct from that of PDE3A ( Fig. 1 ). It is most abundant in the gastrointestinal and cardiovascular systems ( Fig. 1 C and Fig. 3 ,A-D). In the intestine, it is concentrated in the epithelium as well as developing smooth muscle. It is concentrated in the endothelium and smooth muscle of arteries and veins of all caliber (Fig. 3 , A-D). The high level of PDE3B mRNA hybridization in the E20 lung arises from the vasculature as well as bronchial smooth muscle and epithelium (Fig. 3, C and D) . PDE3B is also expressed in myocardium, first noted at E15 (Fig. 3 , E and F). PDE3A and PDE3B mRNAs are expressed in differential cell populations of the developing brain (Fig. 1, B and C) and demonstrate distinct developmental regulation (data not shown, Reinhardt, R. R., and C. A. Bondy, manuscript in preparation). Nonspecific signal as assessed by hybridization of parallel sections with sense probes for each transcript was very low (Figs. 1, D and E, and 2, E and F).
Patterns of Phosphodiesterase Expression
PDE3B gene expression demonstrates a highly focal pattern in the developing liver. From E15, this mRNA is intensely concentrated in isolated large cells, which are clearly different from hepatocytes add the usual nonparenchymal hepatic cells.
The PDE3B-positive cells in embryonic liver are so large and the signal so intense that they are easily visible on film autoradiographs ( Fig. 1 C) . These large cells appear multinucleated and thus are likely to be megakaryocytes which are present along with other hematopoietic cells in fetal liver. These cells are still found in the liver 5 d after birth (Fig. 4, A and B ) but disappear thereafter (Fig. 4, C and D) , at the same time that hepatic hematopoiesis ceases, leaving hepatic PDE3B mRNA detected only in endothelium. In contrast, PDE3A mRNA is diffusely expressed by hepatocytes without any apparent change from E15 through adult life (Fig. 4, E and F) . Expression patterns for PDE3A and PDE3B were stable over time in adipose tissue and vasculature, with PDE3A mRNA remaining highly abundant in adult fat (Fig. 5, A and B ) and PDE3B in adult vasculature (Fig. 5, C and D) .
PDE3A and PDE3B demonstrate very interesting patterns of expression in the developing eye (Fig. 6 ). PDE3A mRNA is highly abundant in the embryonic neural retina, which is composed of differentiating neuroepithelial cells (Fig. 6, A and  B) . This mRNA is also present in the bow region of the lens epithelium, where the epithelial cells are differentiating into lens fibers. PDE3B mRNA is confined to the ganglion cell layer, where it seems to be primarily expressed by capillaries sprouting along the inner surface of the retina (Fig. 6 , C and D).
PDE3A and PDE3B mRNAs were also evaluated in the developing and mature rat testis. Very little PDE3A mRNA was detected until after puberty, when high levels appear in the germinal epithelium (Fig. 7, A and B) . The signal is most abundant in seminiferous tubule segments engaged in early stages of spermiogenesis where it is selectively expressed by primary spermatocytes. PDE3B mRNA was detected only in testicular blood vessels (Fig. 7, C and D) . Interestingly, however, PDE3B mRNA was highly abundant in oocytes (Fig. 7 , E and F).
Finally, PDE3A and PDE3B gene expression was compared in the mature rat kidney. PDE3A mRNA is selectively localized in cortical and outer medullary collecting ducts (Fig. 8, A-C) , as well as perinephric fat ( Fig. 8 A) , while PDE3B mRNA is prominently concentrated in the renal vasculature, including the vasa rectae (Fig. 8, D-F) . The tissue specificity and developmental regulation of PDE3 gene expression are compared and summarized in Table I .
Discussion
This is the first study to provide a comprehensive picture of the cell-specific and developmental patterns of PDE3 gene expres-sion in vivo. Although purified PDE3 preparations isolated from various tissues exhibit similar biochemical and pharmacological properties ( 11) , these two PDE3 transcripts (PDE3A and PDE3B) identified by molecular cloning techniques (40, 41) demonstrate differential cellular patterns of gene expression consistent with their derivation from separate genes subject to independent regulation. The present results demonstrate that PDE3A mRNA is highly expressed in adipocytes during embryogenesis and throughout adult life, consistent with previous studies on cultured rat adipocytes and differentiated 3T3-LI adipocytes (41) . PDE3A mRNA is also stably expressed in liver, albeit at lower levels, through development. These findings are consistent with a functional role for insulin activation of adipocyte and hepatic PDE3s in regulation of hormone-stimulated lipolysis and perhaps glycogenolysis (11, 19, 20, 28, 29, (34) (35) (36) (37) (43) (44) (45) . This study has also identified high level PDE3A gene expression in spermatocytes and in neuroepithelium, including the developing neural retina, where PDE3 expression had not been evaluated previously.
The cellular specificity of PDE3B mRNA expression was clearly distinct from that of PDE3A. PDE3B mRNA was most abundant in smooth muscle of vascular, bronchial, gastrointestinal, and genitourinary systems. PDE3 activities have been intensively studied in vascular and tracheo-bronchial smooth muscle where PDE3 inhibitors promote relaxation (15) (16) (17) (18) 24 Semiquantitative comparison of PDE3 mRNA abundance in different cell types and across developmental stages was carried out in tissues which were prepared, hybridized, washed, and exposed together. The rating of relative mRNA abundance applies primarily within the columns since there may be intrinsic differences in hybridization efficiency which make direct comparison of signal intensity generated by different probes problematical. Hybrid signal estimation: (-) not above background, (+) 2-5x background, (++) 6-10x background, (+++) >1Ox background or grains too numerous to count. Absence of developmental regulation means that stable mRNA levels were detected from the time the differentiated tissue first appeared through adulthood. PDE3s showed pronounced developmental regulation in the nervous system, where high levels were seen in early development (although in different cell types) followed by reduced expression in the mature nervous system. ND, not determined.
vious Northern hybridization data (40, 41) , and in presumed megakaryocytes. In addition to the present evidence, the molecular relatedness of the cardiac and platelet PDE3 is supported by the fact that human PDE3B cDNA was cloned from a cardiac cDNA library using oligonucleotide probes based on the amino acid sequence of peptides isolated from proteolytic digests of purified human platelet PDE3 (40) . Furthermore, the deduced sequence of the catalytic domain of the cardiac PDE3B cDNA is very similar to the partial peptide sequences obtained from the purified platelet PDE3 (40) . PDE3 inhibitors serve both as potent inotropic agents (23-25) and inhibitors of platelet aggregation (26, 27, 30) in humans, although they are much less effective in stimulating myocardial contractility in rats (46) . While a role for PDE3B in smooth and cardiac muscle has been established, its function in vascular endothelium and respiratory and gastrointestinal epithelium, where this study has also demonstrated high level PDE3B gene expression, is as yet unknown. PDE3B mRNA was also found to be highly expressed in rat oocytes. In frog (Xenopus) oocytes, insulin activation of a cAMP phosphodiesterase is associated with oocyte maturation and this process can be blocked by PDE3 inhibitors but not by type IV PDE (PDE4) inhibitors (47, 48) . The role of PDE3s in oocytes and spermatocytes is unknown, but the high level of PDE3 gene expression in rat gametes suggests, if extrapolated to humans, that therapy with PDE3 inhibitors must consider potential effects on germ cells. Additionally, both PDE3B and PDE3A mRNAs are highly expressed and developmentally regulated in the nervous system. The two mRNAs are, however, expressed by different cell populations and exhibit different spatiotemporal profiles during development (Reinhardt, R. R., and C. A. Bondy, manuscript in preparation). Differential cellular patterns of expression of PDE subfamily members are not unique to the PDE3s, as shown in two recent in situ hybridization studies in adult rodent brain (49, 50) which demonstrated overlapping as well as distinctive neuronal patterns of expression of the 61-and 63-kD calmodulin-sensitive PDEs (PDE1), which are also products of different genes (5) (6) (7) .
If the PDE3 steady state mRNA levels described in this study are found to correlate with cellular enzyme levels, it will suggest new layers of complexity to the regulation of cyclic nucleotide phosphodiesterases and will have significant implications as to their cellular functions. In addition to understanding mechanisms for cellular distribution and regulation of the seven different PDE gene subfamilies (1-3), similar consideration must now be extended to individual PDE subfamily members.
PDE3A and PDE3B each represent distinct gene products which exhibit differential jurisdictions and which presumably will be subject to different cell-specific mechanisms for regulation of gene expression. Previous physiological data combined with the present anatomical information suggest that PDE3B has a unified function in regulation of cyclic nucleotide levels in visceral smooth muscle, platelets, and myocardium, while PDE3A primarily contributes to regulating cyclic nucleotide levels in adipocytes and hepatocytes. Thus PDE3A is probably devoted primarily to regulation of insulin-induced lipolysis and glycogenolysis while PDE3B is involved in hormonal regulation of myocardial and smooth muscle contractility and platelet aggregation. Our observations, taken together with those of others concerning the distribution of mRNA of calmodulin-sensitive PDEs in brain (49, 50) , support the view that PDE subfamily members serve specific functional roles. The possibility that these two PDE3s have discrete, tissue-specific functional roles has implications for development of therapeutic agents, in terms of targeting drug delivery to specific cell types and the development of inhibitors selective for specific phosphodiesterases.
